ULLRICH SCHWERTSCHLAG, M.D.
Osteopathic Medicine at Stone Ridge Rd, Beverly Farms, MA
License number
Massachusetts 81959
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
3 Stone Ridge Rd, Beverly Farms, MA 01915
Phone
(978) 921-5237
Professional information
Expression Profiles Of Peripheral Blood Mononuclear Cells For Inflammatory Bowel Diseases
US Patent:
2007002, Jan 25, 2007
Filed:
Jun 6, 2006
Appl. No.:
11/448611
Inventors:
Michael Burczynski - Collegeville PA, US
Ron Peterson - North Chelmsford MA, US
Natalie Twine - Goffstown NH, US
Andrew Strahs - Maynard MA, US
Frederick Immermann - Suffern NY, US
Ullrich Schwertschlag - Beverly Farms MA, US
Monette Cotreau - Acton MA, US
Andrew Dorner - Lexington MA, US
Ron Peterson - North Chelmsford MA, US
Natalie Twine - Goffstown NH, US
Andrew Strahs - Maynard MA, US
Frederick Immermann - Suffern NY, US
Ullrich Schwertschlag - Beverly Farms MA, US
Monette Cotreau - Acton MA, US
Andrew Dorner - Lexington MA, US
International Classification:
C12Q 1/68, C12P 19/34
US Classification:
435006000, 435091200
Abstract:
The present invention is directed to the identification of PBMC- and IBD-associated biomarkers that may be used to diagnose inflammatory bowel disease, and optionally, distinguish between PBMCs isolated from a patient with Crohn's disease and PBMCs isolated from a patient with ulcerative colitis. The present invention is further directed to methods of screening, including high throughput methods of screening, for regulatory agents capable of regulating the activity of PBMC- and IBD-associated biomarkers. Provided are compositions of PBMC- and IBD-associated biomarkers, including regulatory agents of at least one PBMC- and IBD-associated biomarker for methods of diagnosis, prognosis, therapeutic intervention and prevention of an inflammatory bowel disease, e.g., Crohn's disease and ulcerative colitis. Moreover, the present invention is also directed to methods that can be used to assess the efficacy of test compounds and therapies in the treatment inflammatory bowel disease, i.e., Crohn's disease or ulcerative colitis.
Methods Of Treating Inflammatory Bowel Diseases By Administering Il-11
US Patent:
6126933, Oct 3, 2000
Filed:
Oct 26, 1998
Appl. No.:
9/179026
Inventors:
Nick W. Warne - Andover MA
Camille L. Bedrosian - Belmont Hills MA
James C. Keith - Andover MA
Ullrich S. Schwertschlag - Beverly Farms MA
Paul F. Schendel - Wayland MA
Camille L. Bedrosian - Belmont Hills MA
James C. Keith - Andover MA
Ullrich S. Schwertschlag - Beverly Farms MA
Paul F. Schendel - Wayland MA
Assignee:
Genetics Institute - Cambridge MA
International Classification:
A61K 3819
US Classification:
424 852
Abstract:
Provided by the present invention are topical formulations of Interleukin-11 and methods for treating a variety of disorders, including inflammatory bowel diseases (e. g. , Crohn's disease, ulcerative colitis, indeterminate colitis, and infectious colitis), mucositis (e. g. , oral mucositis, gastrointestinal mucositis, nasal mucositis, and proctitis), necrotizing enterocolitis, inflammatory skin disorders (e. g. , psoriasis, atopic dermatitis, and contact hypersensitivity), aphthous ulcers, pharyngitis, esophagitis, peptic ulcers, gingivitis, periodontitis, and ocular diseases (e. g. , conjunctivitis, retinitis, and uveitis).
Dr. Ullrich Schwertschlag, Beverly MA - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Clinical Pharmacology
Address:
3 Stone Ridge Rd, Beverly 01915
(978) 921-5237 (Phone)
320 Newbury St STE 102, Danvers 01923
820 Peter Ct, Vernon Hills 60061
(978) 257-1926 (Phone)
(978) 921-5237 (Phone)
320 Newbury St STE 102, Danvers 01923
820 Peter Ct, Vernon Hills 60061
(978) 257-1926 (Phone)
Languages:
English
Method Of Using Il-11 For Treating Mucositis
US Patent:
6887461, May 3, 2005
Filed:
Jun 27, 2000
Appl. No.:
09/604378
Inventors:
Nick W. Warne - Andover MA, US
Camille L. Bedrosian - Belmont Hills MA, US
Ullrich S. Schwertschlag - Beverly Farms MA, US
Paul F. Schendel - Wayland MA, US
Camille L. Bedrosian - Belmont Hills MA, US
Ullrich S. Schwertschlag - Beverly Farms MA, US
Paul F. Schendel - Wayland MA, US
Assignee:
Genetics Institute, LLC - Cambridge MA
International Classification:
A61K038/19, A61K038/00
US Classification:
424 852, 424 851, 514 2, 514 12
Abstract:
Provided by the present invention are topical formulations of Interleukin-11 and methods for treating a variety of disorders, including inflammatory bowel diseases (e. g. , Crohn's disease, ulcerative colitis, indeterminate colitis, and infectious colitis), mucositis (e. g. , oral mucositis, gastrointestinal mucositis, nasal mucositis, and proctitis), necrotizing enterocolitis, inflammatory skin disorders (e. g. , psoriasis, atopic dermatitis, and contact hypersensitivity), aphthous ulcers, pharyngitis, esophagitis, peptic ulcers, gingivitis, periodontitis, and ocular diseases (e. g. , conjunctivitis, retinitis, and uveitis).
Topical Formulation For Delivery Of Interleukin-11
US Patent:
2005012, Jun 16, 2005
Filed:
Feb 3, 2005
Appl. No.:
11/050246
Inventors:
Nick Warne - Andover MA, US
Camille Bedrosian - Belmont Hills MA, US
James Keith - Andover MA, US
Ullrich Schwertschlag - Beverly Farms MA, US
Paul Schendel - Wayland MA, US
Camille Bedrosian - Belmont Hills MA, US
James Keith - Andover MA, US
Ullrich Schwertschlag - Beverly Farms MA, US
Paul Schendel - Wayland MA, US
International Classification:
A61K038/20
US Classification:
424085200
Abstract:
Provided by the present invention are topical formulations of Interleukin-11 and methods for treating a variety of disorders, including inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis, indeterminate colitis, and infectious colitis), mucositis (e.g., oral mucositis, gastrointestinal mucositis, nasal mucositis, and proctitis), necrotizing enterocolitis, inflammatory skin disorders (e.g., psoriasis, atopic dermatitis, and contact hypersensitivity), aphthous ulcers, pharyngitis, esophagitis, peptic ulcers, gingivitis, periodontitis, and ocular diseases (e.g., conjunctivitis, retinitis, and uveitis).